Acyclic Nitrogen Bonded Directly To The -c(=x)- Group Patents (Class 548/308.4)
  • Electrolyte solution additive containing isocyanate and sulfamide structural groups and application thereof
    Patent number: 12166176
    Abstract: An isocyanate electrolyte solution additive containing a sulfamide structural group has a structure of formula I: where R1 and R2 are identical or different, R1 and R2 are each independently selected from methyl, ethyl, butyl, methoxy, methanesulfonyl, ethanesulfonyl, fluorosulfonyl, trifluoromethanesulfonyl, perfluoroethylsulfonyl, benzenesulfonyl, alkyl-containing benzenesulfonyl, cyano/fluorobenzenesulfonyl and alkoxy-containing benzenesulfonyl, and R1 and R2 can be linked to form one of five-membered ring or six-membered ring.
    Type: Grant
    Filed: October 16, 2023
    Date of Patent: December 10, 2024
    Assignee: Valiant Co., Ltd
    Inventors: Huanjie Wang, Yu Shi, Cunsheng Lin, Shanguo Zhang, Liqi Xuan, Heng Jiang
  • Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
    Patent number: 7141594
    Abstract: Selected heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease. The present invention relates to such retroviral protease inhibitors and, more particularly, relates to selected novel compounds, composition and method for inhibiting retroviral proteases, such as human immunodeficiency virus (HIV) protease, prophylactically preventing retroviral infection or the spread of a retrovirus, and treatment of a retroviral infection.
    Type: Grant
    Filed: November 19, 2003
    Date of Patent: November 28, 2006
    Assignee: G. D. Searle & Co.
    Inventors: Daniel P. Getman, Gary A. DeCrescenzo, John N. Freskos, Michael L. Vazquez, James A. Sikorski, Balekudru Devadas, Srinivasan Nagarajan, David L. Brown, Joseph J. McDonald
  • Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
    Patent number: 6673822
    Abstract: Selected heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease. The present invention relates to such retroviral protease inhibitors and, more particularly, relates to selected novel compounds, composition and method for inhibiting retroviral proteases, such as human immunodeficiency virus (HIV) protease, prophylactically preventing retroviral infection or the spread of a retrovirus, and treatment of a retroviral infection.
    Type: Grant
    Filed: April 12, 2002
    Date of Patent: January 6, 2004
    Assignee: G.D. Searle & Co.
    Inventors: Daniel P Getman, Gary A DeCrescenzo, John N Freskos, Michael L Vazquez, James A Sikorski, Balekudru Devadas, Srinivasan Nagarajan, David L Brown, Joseph J McDonald
  • Imidazole and benzimidazole caspase inhibitors and uses thereof
    Publication number: 20020169177
    Abstract: This invention provides caspase inhibitors having the formula: 1
    Type: Application
    Filed: November 19, 2001
    Publication date: November 14, 2002
    Inventors: David Kay, Julian M.C. Golec
  • Compounds and methods for use thereof in the treatment of cancer or viral infections
    Patent number: 6407105
    Abstract: Benzimidazole derivatives and salts and prodrugs thereof are disclosed, together with methods for the treatment of cancers or viral infections in warm blooded animals by administration of these compounds. Such compounds may be used in combination with a chemotherapeutic agent and/or a potentiator.
    Type: Grant
    Filed: September 26, 2000
    Date of Patent: June 18, 2002
    Assignee: The Procter & Gamble Company
    Inventors: James C. Quada, Jr., Joseph K. Agyin, James Berger Camden